ARTV
Artiva Biotherapeutics, Inc.
6.80$
-2.9%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +6.8% | -1.2% | +2.7% | +4.0% | -2.1% | +2.3% | +2.1% | -52.4% | +260.0% | -39.3% | +103.9% | – | |
| – | +1.5% | +1.0% | +5.5% | +28.6% | +14.5% | -6.0% | -24.5% | +5.3% | -2.6% | +0.3% | +117.1% | – | |
| – | – | – | – | – | -110.3% | – | – | – | -230.4% | – | +336.6% | – | |
| – | +255.3% | -97.2% | +2,477.8% | -79.3% | -33.3% | +698.4% | +106.5% | -43.1% | -29.8% | -42.5% | +171.5% | – | |
| – | +441.2% | – | -86.2% | -9,783.3% | -99.3% | – | +111.8% | -22.9% | -1.5% | -4.5% | +114.8% | – | |
| – | – | – | – | – | -102.5% | – | – | – | – | – | – | – | |
| – | – | – | – | – | -13.2% | +0.0% | +0.0% | -3.0% | +6.3% | -2.9% | -63.6% | – | |
| – | -95.9% | -100.0% | – | – | -100.0% | – | -130.1% | -48.6% | +227.0% | -7.4% | – | – | |
| – | -201.6% | – | – | – | -172.3% | – | – | – | – | -581.6% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.